Lisle M. Nabell

Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

Ayca Gucalp, Sara M. Tolaney, Steven J. Isakoff et al. · Clinical Cancer Research · 2013 · 740 citations

Medicine, Oncology, Pharmacology +16

Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Robert A. Swarm, Judith A. Paice, Doralina L. Anghelescu et al. · Journal of the National Comprehensive Cancer Network · 2019 · 603 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

Eben L. Rosenthal, Jason M. Warram, Esther de Boer et al. · Clinical Cancer Research · 2015 · 478 citations

Medicine, Oncology, Pharmacology +15

Factors Associated With Long-Term Dysphagia After Definitive Radiotherapy for Locally Advanced Head-and-Neck Cancer

Jimmy J. Caudell, Philip E. Schaner, Ruby F. Meredith et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 317 citations

Medicine, Oncology, Radiation Oncology +13

Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC

Lillian L. Siu, Caroline Even, Éva Remenár et al. · JAMA Oncology · 2018 · 310 citations · Full text

Medicine, Oncology, Pharmacology +17